导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.92% | 749/1050 |
| 近一周 | -2.48% | 613/1104 |
| 近一月 | -7.33% | 861/1102 |
| 近一季 | -10.16% | 819/1092 |
| 近半年 | -5.82% | 671/1070 |
| 近一年 | 2.97% | 528/1018 |
| 近两年 | 40.64% | 590/926 |
| 近三年 | 0.58% | 677/833 |
| 成立以来 | 113.72% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.56% 965/1070 |
30.35% 313/1101 |
- - |
- - |
| 2025 | 35.71% 384/1065 |
0.95% 724/1014 |
-3.44% 908/1038 |
41.41% 170/1050 |
-1.55% 535/1065 |
| 2024 | -14.86% 854/1011 |
-7.23% 661/960 |
-5.76% 677/983 |
10.43% 591/991 |
-11.82% 951/1011 |
| 2023 | -20.99% 695/952 |
1.40% 545/880 |
-3.04% 378/895 |
-13.53% 741/915 |
-7.07% 683/952 |
| 2022 | -31.89% 661/867 |
-17.76% 413/773 |
8.72% 317/806 |
-18.57% 726/845 |
-6.45% 684/867 |
| 2021 | 23.80% 127/740 |
0.25% 142/580 |
25.34% 81/659 |
-0.20% 217/704 |
-1.28% 488/740 |
| 2020 | 132.16% 3/554 |
-4.28% 266/419 |
32.38% 95/466 |
33.99% 2/517 |
36.73% 16/554 |
| 2019 | 55.67% 106/410 |
28.68% 445/1146 |
-6.12% 783/1228 |
4.34% 212/390 |
23.51% 6/410 |
| 2018 | - - |
- - |
- - |
-3.79% 405/1000 |
-10.50% 331/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 创金合信工业周期股票A VS. 东吴新产业精选股票A(580008) |